Navigation Links
Henry Gabelnick receives lifetime achievement award
Date:5/27/2010

Arlington, VA (May 27, 2010) -- CONRAD is pleased to announce that Executive Director, Henry Gabelnick, Ph.D, was awarded the lifetime achievement award at the 6th International Microbicides 2010 Conference. This year's conference, Building Bridges to HIV Prevention, was held in Pittsburgh, Pennsylvania May 22-25 and before an audience of more than 1,000 HIV advocates and scientists, Dr. Gabelnick was recognized for his unparalleled commitment and dedication to the development of microbicides. The lifetime achievement award was his second in 2005, Dr. Gabelnick was recognized by the International Conference on AIDS India for a lifetime devoted to reproductive health.

"In a field with so many dedicated, brilliant and persistent researchers, I am tremendously honored to be singled out by my peers," said Dr. Gabelnick. His acceptance speech described his early years working in the chemical industry, specifically in the field of plastics, and his journey to more fulfilling work in the field of contraception and microbicides. Dr. Gabelnick received his undergraduate and graduate degrees at MIT and his doctorate from Princeton. After beginning his career in the chemical industry, Dr. Gabelnick moved to the Biomedical Engineering Branch of the National Institutes of Health. He joined CONRAD at its inception in 1986, and focused primarily on developing new methods of contraception until it became clear that HIV prevention was crucial to overall reproductive health. For the past 20 years, CONRAD has contributed to the microbicide development field through the development of preclinical algorithms and primate models, standardization of colposcopy techniques, biomarker research and clinical trials.

CONRAD scientists also presented the following study findings and analyses at various sessions during the conference:

  • Christine Mauck, M.D., M.P.H. - Assessing Markers of Inflammation after Vaginal Product Use: Nonoxynol-9, Cellulose Sulfate, and HEC Placebo Comparative Double-Blind Phase I Trial and Colposcopy: Still Useful in Microbicide Safety Trials?
  • Gustavo Doncel, M.D., Ph.D. - Combining HIV Prevention and Contraception Technologies
  • Mohammed Saifuddin, D.V.M., Ph.D. - Evaluation of 6% Cellulose Sulfate and 0.5% PRO2000 Gel Microbicide Efficacy in a Single-Dose Intravaginal R5+X4 SHIV Infection Model in Rhesus Macaques Pre-treated with Depo-Provera
  • Irina Zalenskaya, Ph.D. - Gene Expression Profile of Vaginal Epithelial Cells Exposed to Proinflammatory Agents - Identification of Novel Biomarkers of Mucosal Safety
  • Jill Schwartz, M.D. - Pilot Clinical Pharmacokinetic and Pharmacodynamic Study of UC781 Vaginal Gel


'/>"/>

Contact: Annette Larkin
larkinannette@yahoo.com
703-772-6427
CONRAD
Source:Eurekalert

Related medicine news :

1. Henry Ford Hospital study: Fewer infections with new heart-pump implant
2. Henry Ford Hospital: New left-side heart pump improves right-side heart function
3. Henry Ford Hospital study: Less prep needed for colonoscopy
4. Henry Ford Health System goes radical: Creating the hospital of the future
5. Henry Ford Hospital atudy: Hepatitis C infection doubles risk for kidney cancer
6. Henry Ford Hospital study: Shoulder function not fully restored after surgery
7. Henry Ford Hospital study shows link between vitamin D, skin cancer
8. Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus
9. National Press Club to Host NEWSMAKER Media Briefing on Cornhusker Kickback With South Carolina Attorney General Henry McMaster
10. iCIMS Emerges as Talent Management Solution of Choice for Henry Ford Health Systems
11. Health Care Pioneer Henry J. Kaiser Inducted Into The California Hall of Fame
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Steve Helwig & Associates Insurance & Financial, serving ... program, has teamed up with Citizens Opposed to Domestic Abuse in support of its ... support all those victimized by the fear of violence in their own homes, donations ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... enrichment program serving the greater Venice, FL area, has initiated a fundraiser for ... a car accident just four days after Christmas. To support this beautiful child ...
(Date:2/8/2016)... ... February 08, 2016 , ... T.E.N., ... that nominations will be accepted February 8, 2016 through May 8, 2016 ... include the Information Security Executive® of the Year, which recognizes executives who ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... frequently. While a significant number of women and men with eating disorders report ... itself, that best predicts the development of an eating disorder. , At ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... Discover the ... visit over 1,400 booths and 700 companies. Attendees also get to see the ... Colorado Garden & Home Show , at the Colorado Convention Center - 700 ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... -- Vestagen Technical Textiles, Inc., a medical technology company ... other demanding applications, today announced it has named ... Dale Pfost , PhD, who was serving as interim ... Vestagen,s Board of Directors. ® , the ... that combines fluid repellent, antimicrobial and breathability properties. VESTEX ...
(Date:2/8/2016)... Feb. 8, 2016  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... injectable drug delivery systems, today announced that it will release ... December 31, 2015 after market close on February 9, 2016. ... call to discuss these financial results.    About ... --> About Unilife Corporation ...
(Date:2/8/2016)...  Astellas Pharma Inc. President and Chief Executive Officer ... Robinson as president, Americas Operations, for Astellas US LLC, ... South America , effective April 1, 2016.  Robinson ... organization in the United States -- ... Yoshida , who is retiring in June 2016.  ...
Breaking Medicine Technology: